This article is a part of CNN Underscored’s Guide to Age-Defying Beauty, a weeklong focus on the essential products, tips and tricks to enhance your glow at any age. We’ll be featuring editor-tested ...

When one eye is deprived of vision early in life, it can lead to amblyopia, a condition more commonly known as lazy eye. This happens because a lack of input disrupts synapse formation in the brain's ...

It has happened to many of us. While in the middle of work, a study session or just spending time with friends, your eyelid flutters for no apparent reason. At first, it may be nothing more than a ...

A North Carolina mom, frustrated by the difficulty of getting medical help for her daughter, took matters into her own hands and created a solution for parents. Minni Marwaha, a former children's ...

Eye drops combining pilocarpine and diclofenac helped patients read extra lines on vision charts, with effects lasting up to two years. The treatment could revolutionize presbyopia care as a safe, non ...

Back when Alien: Earth premiered on FX and Hulu, all of three weeks ago, IGN’s Clint Gage said in his review of the first two episodes that, “The xenomorph is playing the hits, as it were. But this ...

There’s a dark spot floating in front of your eye, but when you try to look directly at it, it scoots away. What the heck? These little shadows are known as floaters, and like gray hair and laugh ...

What is it, and why does it matter? Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as ...

If you suffer from dry or itchy eyes, listen up: more than 75,000 cases of eye drop solution were voluntarily recalled nationwide by BRS Analytical Service, a pharmaceutical testing lab, according to ...

Systane brand eye drops were voluntarily recalled because of possible fungal contamination, the Food and Drug Administration said. One lot of Systane Lubricant Eye Drops Ultra PF was recalled ...

Charlotte Codina does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...